Gastrointestinal Cancer
GI cancers contribute to 25% of global lifetime cancer risk, with highest risk for death
Researchers estimated the global lifetime risk for developing gastrointestinal cancer in 2020 was one in 12 people, while one in 16 people will die, with colorectal cancer presenting the highest risk compared with other GI cancers.
Type 2 diabetes drug may reduce colorectal cancer risk
Glucagon-like peptide 1 receptor agonists significantly lowered the risk for colorectal cancer in patients with type 2 diabetes compared with other diabetes medications, according to a research letter in JAMA Oncology.
Antidepressant use after diagnosis may reduce liver cancer mortality
Postdiagnosis antidepressant use reduced mortality risk among patients with hepatocellular carcinoma, according to data published in JAMA Network Open.
Up to 70% of premature cancer deaths among women are preventable, WHO-led analysis shows
Nearly seven in 10 premature cancer-related deaths among women could have been avoided through primary prevention, early detection or suitable access to cancer care, according to a report.
Longer-term anticoagulation cuts thrombotic risk for patients with cancer, isolated DVT
In the ONCO-DVT trial, patients with cancer and isolated distal deep vein thrombosis had fewer thrombotic events at 1 year with 12-month vs. 3-month edoxaban therapy, a finding that could change clinical guidance, according to a speaker.
Older female colorectal cancer survivors often experience persistent GI symptoms
More than 80% of older women who survived colorectal cancer experienced a range of gastrointestinal symptoms that sometimes persisted for decades, according to data published in PLOS One.
Cancer incidence continues to rise among younger patients in US
The incidence rate of early-onset cancer significantly increased in the United States from 2010 to 2019, particularly gastrointestinal cancers, according to researchers.
Patients report no quality-of-life issues with adjuvant regimen for high-risk liver cancer
CHICAGO — Individuals with high-risk hepatocellular carcinoma undergoing curative-intent procedures did not experience clinically meaningful deterioration in quality of life or function after adjuvant therapy, phase 3 study results showed.
Elevated BMI in adulthood may increase GI cancer risk, regardless of aspirin use
Overweight and obese BMI during adulthood appeared associated with increased risk for colorectal cancer and noncolorectal gastrointestinal cancers, according to study results published in JAMA Network Open.
Olanzapine effective for chemotherapy-related anorexia among patients with certain cancers
Low-dose olanzapine significantly improved appetite and weight gain among patients with newly diagnosed cancer undergoing chemotherapy, according to study results published in Journal of Clinical Oncology.